Glaxosmithkline Pharmaceuticals: Board Meeting Intimation for Un-Audited Financial Results For The Third Quarter & Nine Months Ended 31St December 2025.

Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve take on record the Un-audited financial results for the third quarter & nine months ended 31st December 2025.